Our company has developed a drug delivery system to specifically treat Alzheimer’s disease.

We call it nano Alzheimer’s Drug Entry Pharmaceutical Target (nano-ADEPT).

The drug design is on the nano scale, which is on the order of 1-100 billionths of a meter. For reference, 1 nano = 3 atoms long.

These Polymeric Nanoparticles will be carriers for the Alzheimer’s drugs already on the market. The complex will be administered by convenient monthly injection, bypass liver metabolism, cross the blood brain barrier efficiently, and supply controlled release of drug at the target areas in the brain.

nano-ADEPT will fulfill all the unmet needs in Alzheimer’s treatment.
It will provide superior treatment over current oral and transdermal patch medication options.